Preconditioning with the low dose of lipopolysaccharide attenuates apoptosis in the heart during septic shock in mice

Pharmacological Reports

Volumn 59, Issue SUPPL. 1, 2007, Pages 161-166

  Kamiński, Karol A ^a   Usowicz Szaryńska, Monika ^a   Kozuch, Marcin ^a   Bonda, Tomasz ^a   Karwowski, Wojciech ^a   Chyczewski, Lech ^a   Sawicki, Bogusław ^a   Musiał, Włodzimierz J ^a   Sobkowicz, Bozena ^a   Winnicka, Maria M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Heart; Lipopolysaccharide; Mice; Preconditioning; Septic shock

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FLUORESCEIN; FORMALDEHYDE; PROTEIN BCL 2; SOLVENT; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ESCHERICHIA COLI; HEART MUSCLE INJURY; HEART PROTECTION; LOW DRUG DOSE; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEPTIC SHOCK; WESTERN BLOTTING;

EID: 38049177895     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Annane D, Bellisant E, Cavaillon JM: Septic shock. Lancet, 2005, 365, 63-78.
2. Beltowski J, Kedra A: Asymmetric: dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacol Rep, 2006, 58, 159-178.
3. Chabowski A, Zmijewska M, Górski J, Kamiński K, Winnicka MM: Effect of IL-6 deficiency on myocardial-expression of fatty acid transporters and intracellular lipid deposits. J Physiol Pharmacol, 2007, 58, 73-82.
4. Dawn B, Xuan Y-T, Gun Y, Rezazadeh A, Stein A, Hunt G, Wu W-J et al: IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res, 2004, 64, 61-71.
5. Dworakowski R, Dworakowska D, Kocic I, Wirth T, Gruchala M, Kaminski M, Petrusewicz J et al.: Cerivastatin and hypercholesterolemia reduce apoptosis of cardiomyocytes in guinea pig papillary muscle subjected to hypoxia/reoxygenation. Pharmacol Rep, 2006, 58, 420-426.
6. Fuchs M, Hilfiker A, Kaminski Y, Hilfiker-Kleiner D, Guener Z, Klein G, Podewski E et al.: Role of interleukin-6 for left ventricular remodeling and survival after experimental myocardial infarction. FASEB J, 2003, 17, 2118-2120.
7. Godlewski G, Schlicker E, Baranowska U, Malinowska B: Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats. Shock, 2006, 26, 10-15.
8. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O: A cathepsin D-cleaved 16kDa form of prolactin mediates postpartum cardiomyopathy. Cell, 2007, 128, 589-600.
9. Jakubowski A, Olszanecki R, Chlopicki S: Involvement of platelet activating factor in immediate heart response to lipopolysaccharide. J Physiol Pharmacol, 2004, 55, 409-421.
10. Kadokami T, Mctiernan CF, Kubota T, Frye CS, Bounoutas GS, Robbins PD, Watkins SC, Feldman AM: Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression. Am J Physiol Heart Circ Physiol, 2001, 280, H2281-H2291.
11. Kaminski KA, Bonda TA, Korecki J, Musiał WJ: Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion injury. Int J Cardiol, 2002, 86, 41-59.
12. Lancel S, Petillot P, Favory R, Stebach N, Lahorte C, Danze PM, Vallet B, et al.: Expression of apoptosis regulatory factors during myocardial dysfunction in endotoxemic rats. Crit Care Med, 2005, 33, 492-496.
13. McDonald TE, Grinman MN, Carthy CM, Walley KR: Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol Heart Circ Physiol, 2000, 279, H2053-H2061.
14. Meng X, Bron JM, Ao L, Rowland RT, Nordeen SK, Banerjee A, Harken AH: Myocardial gene reprogramming associated with cardiac-cross resistance state induced by LPS preconditioning. Am J Physiol Cell Physiol, 1998, 275, C475-C483.
15. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P: Caspage inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med, 2001, 163, 218-225.
16. Petillot P, Lahorte C, Bonanno E, Signore A, Lancel S, Marchetti P, Vallet B et al.: Annexin V detection of lipopolysaccharide-induced cardiac apoptosis. Shock, 2007, 27, 69-74.
17. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K et al.: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell, 1993, 73, 457-467.
18. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP: Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke, 2004, 35, 2576-2581.
19. Saito H, Patterson C, Hu Z, Runge MS, Tipnis U, Sinha M, Papaconstantinou J: Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia. Am J Physiol Heart Circ Physiol, 2000, 279, H2241-H2248.
20. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, Drexler H: Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res, 2000, 87, 1074-1076.
21. Stein AB, Tang XL, Guo Y, Xuan YT, Dawn B, Bolli R: Delayed adaptation of the heart to stress: late preconditioning. Stroke, 2004, 35, Suppl 1, 2676-2679.
22. Suliman HB, Welty-Wolf KE, Carrawaya MS, Tatroa L, Piantadosi CA: Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res, 2004, 64, 279-288.
23. Titheradge MA: Nitric oxide in septic shock. Biochim Biophys Acta, 1999, 1411, 437-455.
24. Wang YP, Sato C, Mizoguchi K, Yamashita Y, Oe M, Maeta H: LPS triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res, 2002, 56, 33-42.